Showing 1-10 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A glucose-responsive cannula of insulin delivery | Cornell University | Bo Wang | Improving Lives | 01-March-2023 to 28-February-2025 | $181.628,32 |
| Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. | The University of Chicago | Piotr Witkowski | Cures | 01-September-2025 to 31-August-2029 | $8.500.000,00 |
| microRNAs as regulators of stem cell differentiation into islet cells | University of Washington | Vincenzino Cirulli | Cures | 01-August-2025 to 31-July-2027 | $600.000,00 |
| Mechanisms of B Cell Polyreactivity in Autoimmunity: Toward Precision Immunotherapy | Regents of the University of Colorado | Elena Hsieh | Cures | 01-September-2025 to 31-August-2026 | $149.965,60 |
| Broad Scope CMC, Non-Clinical, and Regulatory Support | Dark Horse Consulting | Nathan Manley | Cures | 01-September-2025 to 31-December-2026 | $85.000,00 |
| Demand for Combined CGM-Pump Devices in Type 1 Diabetes | Magnolia Innovation, LLC | Kenneth Howie | Improving Lives | 01-August-2025 to 15-February-2026 | $291.000,00 |
| Ad Hoc Consulting Support | Biologics Consulting Group, Inc. | Diana Colleluori | Cures | 01-July-2025 to 30-November-2025 | $61.475,00 |
| Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas | University of Miami | Dirk Homann | Cures | 01-April-2025 to 31-March-2026 | $53.972,92 |
| Safety and Efficacy of Adjunct Therapies in Adults with Type 1 diabetes: multicenter, registry-based study | Trustees of Indiana University | Viral Shah | Improving Lives | 01-September-2025 to 31-August-2028 | $1.603.777,39 |
| Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells | East Tennessee State University | Anoop Arunagiri | Cures | 01-August-2025 to 31-July-2027 | $241.431,00 |